
Govt initiates raft of measures to shore up medical infrastructure
According to the officials, just two days ago, the Medical and Health Services Recruitment Board issued a notification to fill 607 assistant professor posts. The Finance Department approved the recruitment of an additional 714 posts, which will be filled shortly. Since direct recruitment for Associate Professor, Professor, and Additional DME posts was not permissible, these positions are being filled through promotions. To enable this, the government has granted panel year relaxation, according to Medical Education officials.
The government has begun promoting around 231 Assistant Professors as Associate Professors. Promotions have been granted to 308 Associate Professors, elevating them to Professor positions. This move will address shortages of Professors and Heads of Departments across colleges.
Additionally, 44 eligible senior professors have been promoted as Additional Directors of Medical Education. These promotions will result in the appointment of regular Principals in all 34 government medical colleges and regular Superintendents in teaching hospitals.
Regarding the Infrastructure, by 2021, Telangana had only nine medical colleges. The then government established eight colleges in 2022 and another nine in 2023. In 2024, GOs were issued for setting up 8 more colleges. However, in 2022 and 2023, 17 colleges were started without dedicated college buildings, hostel buildings, or affiliated hospitals. The previous government obtained approvals from the NMC by showcasing rented buildings and warehouses as colleges, despite lacking even basic facilities. As a result, the sudden increase in colleges from nine to 34 led to severe shortages of faculty and essential infrastructure.
To overcome these challenges and systematically develop the colleges and teaching hospitals, the present government laid out a clear roadmap. Through GO 276, Medical College Monitoring Committees (MCMCs) were constituted.
These committees are visiting all colleges to assess and report on multiple aspects to the government, including infrastructure, human resources, academic and curriculum readiness, student welfare and amenities, operational and financial aspects, digital systems and IT Infrastructure. Based on their reports, the government is taking steps to develop each college and hospital.
On the new hostels and reconstruction of Osmania, Raja Narsimha said that for a decade, junior doctors and faculty fought for the construction of a new Osmania Hospital. Fulfilling this long-standing aspiration, the government initiated the construction of the new Osmania Hospital at Goshamahal. In addition, modern hostel buildings worth approximately Rs 127 crore were being built with state-of-the-art facilities for Osmania and Gandhi Medical College students. In all these ways, the government under Chief Minister A Revanth Reddy and Minister Damodar Raja Narsimha is working to honour the aspirations of doctors and fulfill their goals, said a press release issued here on Sunday.
Earlier, the Government has decided to continue the services of 16,448 posts under the DME for another one year, which avoids staffing gaps until regular recruitment happens. As per this GO the government has given approval for the continuation of 16,448 posts under the Director of Medical Education (DME) for one more year from April 1, 2025 to March 31, 2026.
The posts include 4,772 Contract posts, 8,615 Outsourcing posts, 3,056 Honorarium posts, 5 MTS (Multi-tasking staff). These posts cover all govt medical colleges, teaching hospitals, nursing and dental colleges across Telangana. It includes faculty (Professors, SRs), doctors, nurses, paramedical staff, DEOs, Class-IV staff and many support roles. All existing contracts will be renewed and new agreements signed as per norms.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
an hour ago
- Time of India
Kidney racket: HC seeks report from state health officials
Madurai: Madras high court on Tuesday directed the principal secretary of the health and family welfare department and the director of medical and rural health services to file a report on the action taken in connection with the kidney trafficking racket in the state. The court also sought a report from the authorities on the mechanism required to prevent organ theft and organ trading in the state. A division bench of justice S M Subramaniam and justice G Arul Murugan sought the report while hearing a public interest litigation filed by S N Sathishwaran of Ramanathapuram district. The petitioner sought to transfer the investigation to CBI for conducting a fair, impartial, and independent investigation and to take appropriate action against all people involved, irrespective of their political affiliation. The petitioner stated that kidney ailments were on the rise in the last few decades. Due to the advancement in medical technology, kidney transplants substantially increased over the years, particularly in several hospitals across the state. However, a few people were involved in illegalities, including kidney theft and medical irregularities in the transplant of kidneys.. He stated that it came to light that Dhanalakshmi Srinivasan Medical College and Hospital in Perambalur and Cethar Hospital in Trichy were found to have indulged in serious medical malpractice and kidney thefts. The petitioner alleged that both hospitals involved in the racket were connected to political personalities from DMK. The petitioner stated that the racket came to light when videos and testimonies surfaced online featuring workers from Pallipalayam and nearby areas in Namakkal, particularly from power loom and dyeing mill communities, claiming they were lured into selling kidneys for Rs 5 lakh to Rs 10 lakh. Several victims claimed they received much less than promised, even though the recipient paid Rs 10 lakh to the broker. People belonging to the economically weaker sections were abused, and their kidneys were removed. The petitioner also sought an interim direction to the state to constitute an independent, impartial, and competent committee headed by an IAS officer and medical professionals to probe the alleged illegal organ trade and related irregularities, including identification of victims, perpetrators, and institutions involved, and submit a detailed report to the court.


India Today
2 hours ago
- India Today
Stress got you sucking? The rise of adult pacifiers
Stress. Burnout. Sleepless nights. For many adults, these aren't just buzzwords, they're daily realities. But now, some are turning to a surprising tool for relief: adult you read that CRIBS TO CUBICLES: THE PACIFIER COMEBACKWhat was once a baby essential is now making waves in adult lives. Silicone pacifiers—designed for grown-ups—are selling out across e-commerce Priced anywhere between Rs 80 and Rs 5,000 (or $1 and $70), they've become a go-to for those seeking relief from anxiety, insomnia, or even nicotine ARE PEOPLE USING THEM?Fans say they help calm the nerves, ease panic attacks, and promote better sleep. Some even claim pacifiers reduce the urge to smoke or snack, offering a sense of comfort that's oddly have a name for it: regression. Under stress, our brains sometimes seek out familiar, childhood comforts. The act of sucking, as associated with early emotional security, can trigger a calming response in the brain.A VIRAL CRAZE IN CHINAThe trend has exploded in China. On platforms like Weibo, videos featuring adult pacifier use have amassed billions of views. On Taobao, sellers report shipping thousands every month. It's become more than a product—it's a social phenomenon, complete with fan communities and viral Is It Safe? Not are ringing the alarm. Long-term pacifier use can lead to jaw strain, misaligned teeth, bite issues, and even airway obstruction, especially if used during while pacifiers may offer quick comfort, experts caution: they don't actually solve stress, they just mask ALTERNATIVES THAT ACTUALLY HELPIf you're looking to cope with stress, here are safer, expert-recommended options:Chewing gum (satisfies oral fixation without dental risk)Stress balls or fidget toolsMindfulness and meditationJournaling or expressive writingProfessional therapy or counsellingTHE BOTTOM LINEAdult pacifiers may feel comforting at the moment, but they're no long-term solution. Tackling stress takes more than silicone. It means facing the root cause, not just soothing the before you click 'add to cart,' ask yourself: do I need a pacifier or a real pause?- Ends


Business Standard
4 hours ago
- Business Standard
Lupin launches Bosentan tablets for oral suspension in US market
Lupin announced the launch of Bosentan tablets for oral suspension, 32 mg in the United States, following approval received by its alliance partner, NATCO Pharma, from the US Food and Drug Administration (USFDA). According to an exchange filing, NATCO holds exclusive first-to-file status for the product and will benefit from 180-day generic drug exclusivity. The product is the bioequivalent to Tracleer Tablets for Oral Suspension, marketed by Actelion Pharmaceuticals US, Inc. Bosentan is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in pediatric patients aged 3 years and older with idiopathic or congenital PAH to improve pulmonary vascular resistance (PVR), which is expected to result in an improvement in exercise ability. As per IQVIA MAT data for June 2025, Bosentan Tablets (RLD Tracleer) had estimated annual sales of approximately $10 million in the US market. Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Lupins consolidated net profit jumped 52.13% to Rs 1,219.03 crore on 11.78% increase in income from operations to Rs 6,163.75 crore in Q1 FY26 over Q1 FY25. Shares of Lupin declined 0.61% to Rs 1,956.50 on the BSE, while shares of Natco Pharma slipped 0.82% to Rs 885.95 on the BSE.